Bridgeway Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $384K | Hold |
|
|||||
|
2024
Q2 | $418K | Sell |
|
|||||
|
2024
Q1 | $1.12M | Sell |
|
|||||
|
2023
Q4 | $1.69M | Sell |
|
|||||
|
2023
Q3 | $936K | Sell |
|
|||||
|
2023
Q2 | $1.32M | Buy |
|
|||||
|
2023
Q1 | $88.2K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $204K | Sell |
|
|||||
|
2022
Q1 | $734K | Sell |
|
|||||
|
2021
Q4 | $1.1M | Sell |
|
|||||
|
2021
Q3 | $1.18M | Sell |
|
|||||
|
2021
Q2 | $1.17M | Buy |
|
|||||
|
2021
Q1 | $1.14M | Buy |
|
|||||
|
2020
Q4 | $355K | Sell |
|
|||||
|
2020
Q3 | $339K | Sell |
|
|||||
|
2020
Q2 | $541K | Buy |
|
|||||
|
2020
Q1 | $519K | Sell |
|
|||||
|
2019
Q4 | $968K | Buy |
|
|||||
|
2019
Q3 | $957K | Buy |
|
|||||
|
2019
Q2 | $556K | Hold |
|
|||||
|
2019
Q1 | $607K | Buy |
|
|||||
|
2018
Q4 | $193K | Hold |
|
|||||
|
2018
Q3 | $364K | Hold |
|
|||||
|
2018
Q2 | $212K | Hold |
|
|||||
|
2018
Q1 | $124K | Hold |
|
|||||
|
2017
Q4 | $110K | Sell |
|
|||||
|
2017
Q3 | $161K | Hold |
|
|||||
|
2017
Q2 | $229K | Sell |
|
|||||
|
2017
Q1 | $347K | Sell |
|
|||||
|
2016
Q4 | $351K | Hold |
|
|||||
|
2016
Q3 | $618K | Hold |
|
|||||
|
2016
Q2 | $581K | Hold |
|
|||||
|
2016
Q1 | $550K | Hold |
|
|||||
|
2015
Q4 | $990K | Hold |
|
|||||
|
2015
Q3 | $750K | Hold |
|
|||||
|
2015
Q2 | $774K | Buy |
|
|||||
|
2015
Q1 | $798K | Hold |
|
|||||
|
2014
Q4 | $830K | Hold |
|
|||||
|
2014
Q3 | $892K | Buy |
|
|||||
|
2014
Q2 | $455K | Hold |
|
|||||
|
2014
Q1 | $430K | Hold |
|
|||||
|
2013
Q4 | $416K | Hold |
|
|||||
|
2013
Q3 | $431K | Buy |
|
|||||
|
2013
Q2 | $399K | Buy |
|